search
TRex Bio
Trends
- 1Immunology startup TRex Bio sets terms for $133 million IPO▼Immunology startup TRex Bio sets price range for $133 million public debut
Immunology startup TRex Bio has set a price range for an initial public offering expected to raise around $133 million. The company is developing therapies targeting immune-related diseases. The listing comes amid renewed interest in biotech debuts, with investors watching whether clinical-stage immunology companies can attract public market demand.